Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Retained Earnings (2016 - 2025)

Historic Retained Earnings for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to -$415.0 million.

  • AtriCure's Retained Earnings fell 745.03% to -$415.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$415.0 million, marking a year-over-year decrease of 745.03%. This contributed to the annual value of -$401.8 million for FY2024, which is 1251.84% down from last year.
  • As of Q3 2025, AtriCure's Retained Earnings stood at -$415.0 million, which was down 745.03% from -$414.7 million recorded in Q2 2025.
  • AtriCure's 5-year Retained Earnings high stood at -$266.4 million for Q3 2021, and its period low was -$415.0 million during Q3 2025.
  • For the 5-year period, AtriCure's Retained Earnings averaged around -$350.6 million, with its median value being -$347.3 million (2021).
  • Examining YoY changes over the last 5 years, AtriCure's Retained Earnings showed a top increase of 1519.56% in 2021 and a maximum decrease of 37856666.67% in 2021.
  • AtriCure's Retained Earnings (Quarter) stood at -$280.2 million in 2021, then fell by 16.59% to -$326.6 million in 2022, then decreased by 9.32% to -$357.1 million in 2023, then decreased by 12.52% to -$401.8 million in 2024, then decreased by 3.29% to -$415.0 million in 2025.
  • Its Retained Earnings stands at -$415.0 million for Q3 2025, versus -$414.7 million for Q2 2025 and -$408.5 million for Q1 2025.